Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Merkt, W; Salzer, U; Thiel, J; Jandova, I; Bergner, R; Venhoff, AC; Venhoff, N.
Blood CD3-(CD56 or 16)+ natural killer cell distributions are heterogeneous in healthy adults and suppressed by azathioprine in patients with ANCA-associated vasculitides.
BMC Immunol. 2021; 22(1):26
Doi: 10.1186/s12865-021-00416-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Thiel Jens
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Cytotoxic Natural Killer (NK) cells are increasingly recognized as a powerful tool to induce targeted cell death in cancer and autoimmune diseases. Still, basic blood NK cell parameters are poorly defined. The aims of this study were 1) to establish reference values of NK cell counts and percentages in healthy adults; 2) to describe these parameters in the prototype autoimmune disease group ANCA-associated vasculitis (AAV); and 3) to investigate whether NK cell counts and percentages may be used as activity biomarkers in the care of AAV patients, as suggested by a preceding study. METHODS: CD3-(CD56 or 16)+ NK cell counts and percentages were determined in 120 healthy adults. Lymphocyte subset and clinical data from two German vasculitis centers were analyzed retrospectively (in total 407 measurements, including 201/49/157 measurements from 64/16/39 patients with granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA), respectively). RESULTS: CD3-(CD56 or 16)+ NK cell counts and percentages in healthy adults were highly variable, not Gaussian distributed and independent of age and sex. NK cell percentages ranged from 1.9 to 37.9% of lymphocytes, and were significantly more dispersed in AAV (0.3 to 57.6%), while the median percentage was not different between AAV and healthy donors. In contrast, median NK cell counts were significantly lower in AAV compared to healthy donors. Sub-group analyses revealed that NK cell counts were low independent of AAV entity and disease activity. Azathioprine therapy was associated with significantly lower NK cell counts and percentages compared to non-azathioprine therapies. In 13.6% of azathioprine-treated patients, percentages were
- Find related publications in this database (using NLM MeSH Indexing)
- Adult - administration & dosage
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology
- Azathioprine - therapeutic use
- Blood Cells - immunology
- CD3 Complex - metabolism
- CD56 Antigen - metabolism
- Cytotoxicity, Immunologic - administration & dosage
- Female - administration & dosage
- Healthy Volunteers - administration & dosage
- Humans - administration & dosage
- Immunosuppression Therapy - administration & dosage
- Immunosuppressive Agents - therapeutic use
- Killer Cells, Natural - immunology
- Lymphocyte Subsets - immunology
- Male - administration & dosage
- Receptors, IgG - metabolism
- Retrospective Studies - administration & dosage
- Find related publications in this database (Keywords)
- ANCA-associated vasculitis
- Natural killer cells
- Azathioprine